Afanasieva, O.I.; Tyurina, A.V.; Klesareva, E.A.; Arefieva, T.I.; Ezhov, M.V.; Pokrovsky, S.N.
Lipoprotein(a), Immune Cells and Cardiovascular Outcomes in Patients with Premature Coronary Heart Disease. J. Pers. Med. 2022, 12, 269.
https://doi.org/10.3390/jpm12020269
AMA Style
Afanasieva OI, Tyurina AV, Klesareva EA, Arefieva TI, Ezhov MV, Pokrovsky SN.
Lipoprotein(a), Immune Cells and Cardiovascular Outcomes in Patients with Premature Coronary Heart Disease. Journal of Personalized Medicine. 2022; 12(2):269.
https://doi.org/10.3390/jpm12020269
Chicago/Turabian Style
Afanasieva, Olga I., Alexandra V. Tyurina, Elena A. Klesareva, Tatiana I. Arefieva, Marat V. Ezhov, and Sergei N. Pokrovsky.
2022. "Lipoprotein(a), Immune Cells and Cardiovascular Outcomes in Patients with Premature Coronary Heart Disease" Journal of Personalized Medicine 12, no. 2: 269.
https://doi.org/10.3390/jpm12020269
APA Style
Afanasieva, O. I., Tyurina, A. V., Klesareva, E. A., Arefieva, T. I., Ezhov, M. V., & Pokrovsky, S. N.
(2022). Lipoprotein(a), Immune Cells and Cardiovascular Outcomes in Patients with Premature Coronary Heart Disease. Journal of Personalized Medicine, 12(2), 269.
https://doi.org/10.3390/jpm12020269